Moore Capital Management LP boosted its position in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 3.6% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 46,606 shares of the financial services provider's stock after acquiring an additional 1,606 shares during the period. Moore Capital Management LP's holdings in CME Group were worth $10,823,000 as of its most recent SEC filing.
Several other large investors have also recently bought and sold shares of the business. Vanguard Group Inc. lifted its holdings in shares of CME Group by 1.0% in the 4th quarter. Vanguard Group Inc. now owns 34,243,090 shares of the financial services provider's stock valued at $7,952,273,000 after purchasing an additional 326,623 shares during the last quarter. Geode Capital Management LLC boosted its position in shares of CME Group by 1.3% during the 4th quarter. Geode Capital Management LLC now owns 8,389,442 shares of the financial services provider's stock worth $1,946,717,000 after purchasing an additional 104,697 shares in the last quarter. Price T Rowe Associates Inc. MD grew its position in CME Group by 89.9% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 8,280,785 shares of the financial services provider's stock worth $1,923,047,000 after buying an additional 3,921,278 shares during the period. Norges Bank acquired a new stake in shares of CME Group in the 4th quarter worth approximately $1,107,389,000. Finally, FIL Ltd increased its position in shares of CME Group by 1.5% in the fourth quarter. FIL Ltd now owns 4,081,391 shares of the financial services provider's stock valued at $947,821,000 after buying an additional 61,908 shares in the last quarter. Hedge funds and other institutional investors own 87.75% of the company's stock.
Insider Transactions at CME Group
In other CME Group news, COO Suzanne Sprague sold 1,500 shares of the stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $256.83, for a total transaction of $385,245.00. Following the transaction, the chief operating officer now owns 8,036 shares in the company, valued at $2,063,885.88. This trade represents a 15.73% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Hilda Harris Piell sold 3,984 shares of the business's stock in a transaction on Thursday, February 27th. The stock was sold at an average price of $250.47, for a total transaction of $997,872.48. Following the transaction, the insider now directly owns 27,046 shares of the company's stock, valued at approximately $6,774,211.62. This represents a 12.84% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 23,134 shares of company stock valued at $6,087,434 over the last quarter. Company insiders own 0.30% of the company's stock.
CME Group Price Performance
CME Group stock traded up $7.72 during trading hours on Thursday, hitting $274.00. 2,226,208 shares of the company traded hands, compared to its average volume of 2,177,717. CME Group Inc. has a 1-year low of $190.70 and a 1-year high of $286.48. The firm has a market cap of $98.74 billion, a P/E ratio of 28.34, a P/E/G ratio of 6.76 and a beta of 0.45. The firm's 50-day simple moving average is $265.31 and its two-hundred day simple moving average is $246.39. The company has a quick ratio of 1.02, a current ratio of 1.01 and a debt-to-equity ratio of 0.10.
CME Group (NASDAQ:CME - Get Free Report) last released its earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 EPS for the quarter, beating the consensus estimate of $2.61 by $0.19. The business had revenue of $1.64 billion during the quarter, compared to analyst estimates of $1.56 billion. CME Group had a net margin of 57.52% and a return on equity of 13.62%. The business's quarterly revenue was up 10.4% on a year-over-year basis. During the same period in the prior year, the business earned $2.50 earnings per share. As a group, analysts forecast that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.
CME Group Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Wednesday, June 25th. Investors of record on Monday, June 9th will be given a $1.25 dividend. The ex-dividend date is Monday, June 9th. This represents a $5.00 annualized dividend and a dividend yield of 1.82%. CME Group's dividend payout ratio (DPR) is presently 50.30%.
Analysts Set New Price Targets
Several research firms have weighed in on CME. Barclays raised their price target on CME Group from $279.00 to $283.00 and gave the stock an "equal weight" rating in a research report on Wednesday, April 23rd. UBS Group boosted their target price on CME Group from $290.00 to $305.00 and gave the stock a "buy" rating in a report on Friday, April 25th. Royal Bank of Canada reissued a "sector perform" rating and issued a $269.00 price objective on shares of CME Group in a research report on Thursday, April 3rd. Piper Sandler upped their target price on shares of CME Group from $275.00 to $283.00 and gave the company an "overweight" rating in a research note on Tuesday, April 8th. Finally, Erste Group Bank upgraded CME Group to a "strong-buy" rating in a report on Monday, March 17th. Three investment analysts have rated the stock with a sell rating, seven have assigned a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the stock presently has an average rating of "Hold" and an average price target of $256.80.
Check Out Our Latest Analysis on CME Group
CME Group Profile
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Featured Stories

Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report